SCHEMBL754385

SCHEMBL754385

Cc1nc(-c2cccc(Oc3ccc4c(c3)SNCCO4)c2)no1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.45
RAB9A P51151 7/20 0.45
NPC1 O15118 6/20 0.45
TP53 P04637 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
LMNA P02545 3/20 0.45
GAA P10253 2/20 0.45
HTT P42858 2/20 0.45
MAPK1 P28482 2/20 0.45
TUBB4A P04350 4/20 0.43
TUBB P07437 4/20 0.43
TUBA3C P0DPH7 4/20 0.43
TUBA1B P68363 4/20 0.43
TUBA4A P68366 4/20 0.43
TUBB4B P68371 4/20 0.43
TUBB3 Q13509 4/20 0.43
TUBB2A Q13885 4/20 0.43
TUBB8 Q3ZCM7 4/20 0.43
TUBA3E Q6PEY2 4/20 0.43
TUBA1A Q71U36 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL757397 0.78 RAB9A (0.46) L3MBTL1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL797745 0.78 LMNA (0.45) L3MBTL1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL783038 0.74 LMNA (0.42) L3MBTL1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL7425441 0.72 L3MBTL1 (0.60) L3MBTL1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL755478 0.69 LMNA (0.46) L3MBTL1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL758638 0.69 RAB9A (0.50) L3MBTL1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL16067423 0.69 L3MBTL1 (0.72) L3MBTL1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL7421268 0.68 MAPT (0.60) L3MBTL1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL7430617 0.67 L3MBTL1 (0.49) L3MBTL1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL7426351 0.67 L3MBTL1 (0.49) L3MBTL1RAB9ANPC1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431360-B1 Derivatives of dihydrobenzoxathiazepine, method of preparing same and pharmaceutical compositions containing them as well as their uses as modulators of AMPA receptors SERVIER LAB (FR) 2013-04-17 EP disclosed
WO-2012035216-A1 DIHYDROBENZOXATHIAZEPINE DERIVATIVES, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS AND USE AS AMPA RECEPTOR MODULATORS LES LABORATOIRES SERVIER (FR) 2012-03-22 WO disclosed
EP-2431360-A1 Derivatives of dihydrobenzoxathiazepine, method of preparing same and pharmaceutical compositions containing them as well as their uses as modulators of AMPA receptors Les Laboratoires Servier (FR) 2012-03-21 EP disclosed